Optical molecular sensors for cytochrome P450 activity

Details Optical molecular sensors for cytochrome P450 activity Optical molecular sensors for cytochrome P450 activity

1999-04-28

2000-11-07

Leary, Louise N.

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

435 25, 435968, C12Q 100, C12Q 126

Patent

active

061434922

ABSTRACT:
The invention provides a compound, useful as an optical probe or sensor of the activity of at least one cytochrome P450 enzyme, and methods of using the compound to screen candidate drugs, and candidate drugs identified by these methods. The optical probe of the invention is a compound having the generic structure Y-L-Q, wherein Y is selected from the group consisting of Q as herein defined, saturated C.sub.1 -C.sub.20 alkyl, unsaturated C.sub.1 -C.sub.20 alkenyl, unsaturated C.sub.1 -C.sub.20 alkynyl, substituted saturated C.sub.1 -C.sub.20 alkyl, substituted unsaturated C.sub.1 -C.sub.20 alkenyl, substituted unsaturated C.sub.1 -C.sub.20 alkynyl, C.sub.1 -C.sub.20 cycloalkyl, C.sub.1 -C.sub.20 cycloalkenyl, substituted saturated C.sub.1 -C.sub.20 cycloalkyl, substituted unsaturated C.sub.1 -C.sub.20 cycloalkenyl, aryl, substituted aryl, heteroaryl and substituted heteroaryl; L is selected from the group of (--O(substituted ortho-phenyl)CR.sup.2 H).sub.p --, (--O(substituted meta-phenyl)CR.sup.2 H).sub.p --, and (--O(substituted para-phenyl)CR.sup.2 H).sub.p --, wherein for each p, all R.sup.2 are separately selected from the group consisting of a hydrogen atom, saturated C.sub.1 -C.sub.20 alkyl, unsaturated C.sub.1 -C.sub.20 alkenyl, unsaturated C.sub.1 -C.sub.20 alkynyl, substituted saturated C.sub.1 -C.sub.20 alkyl, substituted unsaturated C.sub.1 -C.sub.20 alkenyl, substituted unsaturated C.sub.1 -C.sub.20 alkynyl, C.sub.1 -C.sub.20 cycloalkyl, C.sub.1 -C.sub.20 cycloalkenyl, substituted saturated C.sub.1 -C.sub.20 cycloalkyl, substituted unsaturated C.sub.1 -C.sub.20 cycloalkenyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, and p is a positive integer no greater than twelve; and Q is a chemical moiety that gives rise to optical properties in its hydroxy or hyrdoxylate, phenol or phenoxide form that are different from the optical properties that arise from its ether form. Most preferably, p is one, R.sup.2 is hydrogen, and Q is the ether form of a phenoxide fluorophore.

REFERENCES:
patent: 5110725 (1992-05-01), Marrone et al.
patent: 5208332 (1993-05-01), Marrone et al.
patent: 5304645 (1994-04-01), Klein et al.
patent: 5741657 (1998-04-01), Tsien et al.
Buters, Jeroen, A Highly Sensitive Tool for the Assay of CYP450 Enzyme; Biochemical Pharmacology, vol. 46:9, 1577-84 (1993).
Haasch, Mary, Use of 7-Alkoxyphenoxazones,7-Alkoxycoumarins A. 7-Alkoxyquinolines As Fluorescent Substrates; Biochemical Pharmacology, vol. 47:5, 893-903 (1994).
Krafft, Grant, Photoactivable Fluorophores 3; Journal of the American Chemical Society., vol. 110, 301-303 (1988).
Mace, et al., Development of CYP450-expressing human bronchial epithelial cell lines for in vitro pharmacotoxicologic applications; In Vitro Toxicology, vol. 10, 85-92 (1997).
Mayer, R. T., Alkoxyquinolines: New Fluorescent Substrates for Cytochrome P450 Monooxgenases, Biochemical Pharmacology, vol. 40-5, 1645-55 (1990).
Omata, Yoshiaki, Conformational Change of CYP-450, Biochemica et Biophysica Acta vol. 870, 392-400 (1986).
White, Ian N. H., A Continuous Fluorometric Assay for CYP-450, Analytical Biochemistry, vol. 172-2, 304-310 (1988).
Aitio, Analyt. Biochem., 85:488-91(1978).
Berman et al., J. of Medicinal Chemistry, 40: 827-829 (1997).
Burke et al., Biochem J. 212: 15-24 (1983).
Burke et al., Biochemical Pharmacology, 34: 3337-33345 (1985).
Crespi et al., Advances in Pharmacology, 43: 171-188 (1997).
Crespi, et al., Analytical Biochemistry, 248: 188-190 (1997).
DeLuca et al., Biochemical Pharmacology, 37: 1731-1739 (1988).
Donato et al., Analytical Biochemistry, 213: 29-33 (1993).
Greenlee et al., J. Pharmacology and Experimental Therapeutics, 205: 596-605 (1978).
Gotoh, J. of Biological Chemistry, 267: 83-90 (1992).
Haasch et al., Biochemical Pharmacology, 47: 893-903 (1994).
Kennedy et al., Analytical Biochemistry, 222: 217-223 (1994).
Klotz et al., Analytical Biochemistry, 140: 138-145 (1984).
Kronbach et al., Analytical Biochemistry, 162: 24-32 (1987).
Marrone et al., Endocrinology, 128: 2654-2656 (1991).
Mayer et al., Biochemical Pharmacology, 40: 1645-1655 (1990).
Mayer et al., Biochemical Pharmacology, 38: 1364-1368 (1989).
Miller, Analytical Biochemistry, 133: 46-57 (1983).
Murray, Clinical Pharmacokentic, 23: 133-146 (1992).
Murray et al., Pharmacological Reviews, 42: 85-101 (1990).
Ono et al., Xenobiotica, 26: 681-693 (1996).
Parkinson, Toxicologic Pathology, 24: 45-57 (1996).
Peck et al., J. American Medical Ass., 269: 1550-1552 (1993).
Schalk et al., Biochemistry 36: 15253-15261 (1997).
Simpson et al., J. Org. Chem., 56: 5391-5396 (1991).
Smith et al., Research Focus, 2: 406-414 (1997).
Smith et al., Research Focus, 2: 479-486 (1997).
Smith et al., Biochemical Pharmacology, 44: 2089-2098 (1992).
Thummel et al., Annul. Rev. Pharmacol. Toxicol., 38: 389-430 (1998).
White et al., Biochem. J., 247: 23-28 (1987).
Wrigton et al., J. Pharmacokinetics and Biopharmaceutics, 25: 461-473 (1996).

Affiliated with

Also associated with

Rating

Optical molecular sensors for cytochrome P450 activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Optical molecular sensors for cytochrome P450 activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Optical molecular sensors for cytochrome P450 activity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1639140